0
NovaBay Pharmaceuticals Banner Image

NovaBay Pharmaceuticals

  • Ticker NBY
    Exchange NYSE More
  • Industry Biotechnology More
  • Sector Healthcare More
NovaBay Pharmaceuticals Logo Image
  • 51-200 Employees
  • Based in Emeryville, California
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focusing on commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global, topical anti-infective market with its two distinct product categories: the NEUTROX® family of products and the AGANOCIDE® compounds. The Neutrox family of products includes AVENOVA® for theMore eye care market, NEUTROPHASE® for wound care market, and CELLERX® for the aesthetic dermatology market.
REPORT RATINGS
4.7 / 5.0 (165)

NovaBay Pharmaceuticals reports have an aggregate usefulness score of 4.7 based on 165 reviews.

NovaBay Pharmaceuticals

Most Recent Annual Report

NovaBay Pharmaceuticals
MOST RECENT 2023 Annual Report and Form 10K

NovaBay Pharmaceuticals does not currently have any hardcopy reports on AnnualReports.co.uk. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

NovaBay Pharmaceuticals Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!